Published 1996 | Version v1
Publication

Combination therapy with subcutaneous interleukin-2 and interferon-alpha in advanced renal cancer patients with poor prognostic factors. 1996 Jan-Feb;16(1):541-4.

Additional details

Created:
December 2, 2022
Modified:
November 30, 2023